Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
101.85B | 101.89B | 99.46B | 110.67B | 112.94B | 109.71B | Gross Profit |
25.73B | 28.14B | 27.61B | 31.68B | 32.48B | 30.20B | EBIT |
48.00M | 625.00M | 710.00M | 1.10B | 2.46B | 627.00M | EBITDA |
2.67B | 3.62B | 3.57B | 3.95B | 5.00B | 3.15B | Net Income Common Stockholders |
-1.83B | 451.00M | 205.00M | 368.00M | 878.00M | -220.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
6.49B | 6.03B | 5.35B | 6.15B | 7.72B | 7.18B | Total Assets |
58.60B | 58.19B | 54.26B | 49.37B | 50.90B | 50.28B | Total Debt |
14.02B | 15.58B | 10.42B | 5.29B | 5.48B | 6.52B | Net Debt |
7.53B | 9.96B | 5.06B | -853.00M | -2.24B | -661.00M | Total Liabilities |
31.40B | 29.33B | 25.63B | 20.56B | 22.17B | 22.12B | Stockholders Equity |
27.20B | 28.86B | 28.63B | 28.81B | 28.73B | 28.16B |
Cash Flow | Free Cash Flow | ||||
0.00 | -2.79B | -4.37B | -887.00M | 1.27B | 357.00M | Operating Cash Flow |
0.00 | 1.63B | 1.93B | 2.25B | 5.69B | 3.38B | Investing Cash Flow |
0.00 | -3.54B | -7.13B | -3.11B | -3.60B | -2.43B | Financing Cash Flow |
0.00 | 2.60B | 4.40B | -699.00M | -1.55B | -136.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | ¥38.43B | 14.30 | 2.86% | -1.59% | 57.60% | ||
71 Outperform | ¥391.75B | 19.50 | 11.37% | 1.34% | 17.14% | -14.26% | |
71 Outperform | ¥237.16B | 19.92 | 2.75% | 11.24% | -41.84% | ||
67 Neutral | ¥52.35B | 52.39 | 2.74% | 3.10% | -3.05% | ||
64 Neutral | $8.75B | 14.76 | 4.97% | 174.27% | 3.56% | 3.44% | |
58 Neutral | ¥12.73B | ― | 2.31% | 0.65% | -679.34% | ||
57 Neutral | ¥182.56B | 47.81 | 1.42% | 0.99% | -48.66% |